TABLE 1.
Clinical characteristics of patient groups
| Characteristic | MFS patients | GBS patients |
|---|---|---|
| No. | 13 | 18 |
| Age range (yr) | 12–80, mean 49 | 18–86, mean 48 |
| Sex: female, male | 4f, 9m | 8f, 10m |
| Preceding infection (daysa) | ||
| Respiratory | 6/13 (4–14) | 3/18 (2–7) |
| Gastrointestinal | 5/13 (6–21) | 6/18 (3–17) |
| Unknown | 2/13 | 9/18 |
| Hypo-or areflexia | 13/13 | 18/18 |
| Ataxia | 13/13 | 9/18 |
| Ophthalmoplegia | 13/13 | 0/18 |
| Abducens palsy | 5/18 | |
| Facial palsy | 6/13 | 14/18 |
| Dysarthria | 8/13 | 2/18 |
| Dysphagia | 5/13 | 3/18 |
| First serum sampling (daysb) | ||
| Acute phase | 12/13 (2–18, mean 7) | 17/18 (2–21, mean 11) |
| Recovery phase | 1/13 (61) | 1/18 (38) |
| CSF sampling (daysb) | 3/13 (5–6) | 4/18 (2–15) |
a
Days (range) between onset of preceding infection and onset of neurological symptoms.
b
Days (range) between onset of neurological symptoms and serum sampling.